Vanguard Group’s DARA BIOSCIENCES INC COM STK (DE) DARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-104,369
Closed -$89K 4278
2015
Q3
$89K Buy
104,369
+6,088
+6% +$5.24K ﹤0.01% 4103
2015
Q2
$90K Buy
98,281
+7,500
+8% +$6.18K ﹤0.01% 4124
2015
Q1
$66K Buy
90,781
+21,300
+31% +$17.9K ﹤0.01% 4108
2014
Q4
$61K Hold
69,481
﹤0.01% 4013
2014
Q3
$75K Buy
69,481
+36,711
+112% +$45.6K ﹤0.01% 3978
2014
Q2
$40K Sell
32,770
-70,783
-68% -$118K ﹤0.01% 3957
2014
Q1
$286K Buy
103,553
+97,999
+1,764% +$304K ﹤0.01% 3759
2013
Q4
$15K Hold
5,554
﹤0.01% 3896
2013
Q3
$14K Hold
5,554
﹤0.01% 3834
2013
Q2
$17K Buy
+5,554
New +$20.6K ﹤0.01% 3789

Vanguard Group's DARA Position: Q4 2015 in Review

Vanguard Group sold out of DARA BIOSCIENCES INC COM STK (DE) (DARA) in Q4 2015, closing a stake of 104,369 shares — an estimated $89K sold.

Vanguard Group first reported a position in DARA in Q2 2013 and held it in 10 quarters. The position peaked at $286K in Q1 2014. 0 funds tracked by Wall St. Rank hold DARA as of Q4 2015.

  • Vanguard Group reported no remaining DARA BIOSCIENCES INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Vanguard Group sold 104,369 DARA BIOSCIENCES INC COM STK (DE) shares in Q4 2015, an estimated $89K.
  • Vanguard Group first reported a position in DARA BIOSCIENCES INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Vanguard Group's DARA BIOSCIENCES INC COM STK (DE) position peaked at $286K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held DARA BIOSCIENCES INC COM STK (DE) as of Q4 2015.

Based on Vanguard Group's 13F filing for Q4 2015, filed 8 Feb 2016.